Aldeyra Therapeutics, Inc. (ALDX)
NASDAQ: ALDX · Real-Time Price · USD
1.585
+0.065 (4.28%)
At close: Jul 27, 2026, 4:00 PM EDT
1.760
+0.175 (11.04%)
Pre-market: Jul 28, 2026, 5:45 AM EDT
Aldeyra Therapeutics Employees
Aldeyra Therapeutics had 7 employees as of March 31, 2026. The number of employees decreased by 1 or -12.50% compared to the same quarter last year.
Employees
7
Change
-1
Growth
-12.50%
Revenue / Employee
n/a
Profits / Employee
-$3,909,968
Market Cap
95.61M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 7 | -1 | -12.50% |
| Dec 31, 2025 | 8 | -1 | -11.11% |
| Sep 30, 2025 | 8 | -1 | -11.11% |
| Jun 30, 2025 | 8 | -2 | -20.00% |
| Mar 31, 2025 | 8 | -2 | -20.00% |
| Dec 31, 2024 | 9 | -1 | -10.00% |
| Sep 30, 2024 | 9 | -3 | -25.00% |
| Jun 30, 2024 | 10 | -5 | -33.33% |
| Mar 31, 2024 | 10 | -5 | -33.33% |
| Dec 31, 2023 | 10 | -5 | -33.33% |
| Sep 30, 2023 | 12 | -3 | -20.00% |
| Jun 30, 2023 | 15 | 1 | 7.14% |
| Mar 31, 2023 | 15 | 1 | 7.14% |
| Dec 31, 2022 | 15 | 3 | 25.00% |
| Sep 30, 2022 | 15 | 4 | 36.36% |
| Jun 30, 2022 | 14 | 4 | 40.00% |
| Mar 31, 2022 | 14 | 6 | 75.00% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Gossamer Bio | 162 |
| Pelthos Therapeutics | 92 |
| Verrica Pharmaceuticals | 76 |
| ImmuCell | 73 |
| Rani Therapeutics Holdings | 71 |
| Biomea Fusion | 40 |
| Oncolytics Biotech | 29 |
| Black Diamond Therapeutics | 21 |
ALDX News
- 21 days ago - Levicept Appoints Darlene Deptula-Hicks as CFO - GlobeNewsWire
- 6 weeks ago - Aldeyra Therapeutics Appoints Darlene Deptula-Hicks to Board of Directors - Business Wire
- 7 weeks ago - Aldeyra Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Aldeyra Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference - Business Wire
- 2 months ago - Shareholders Sue Aldeyra Therapeutics Over Dry Eye Drug Claims - TipRanks
- 2 months ago - Aldeyra Therapeutics Quarterly report: Q1 2026 - Filings
- 3 months ago - REMINDER: Aldeyra Therapeutics, Inc. Investors With Significant Losses Must Act By May 29, 2026 - GlobeNewsWire
- 3 months ago - Aldeyra Therapeutics Proxy statement: Proxy filing - Filings